Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Sep;14(3):716-20.
doi: 10.1128/iai.14.3.716-720.1976.

Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans

Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans

R D Diamond et al. Infect Immun. 1976 Sep.

Abstract

Studies were performed to identify the types of human peripheral blood leukocytes capable of killing Cryptococcus neoformans in the presence of anticryptococcal antibody in vitro. A total of 24.1 +/- 2.7% (mean +/- standard error of the mean of four experiments) of the original cryptococcal inoculum survived in a mixed mononuclear, cell preparation (approximately 30% monocytes) after 4 h of incubation at 37 degrees C with rabbit anticryptococcal antibody. When phagocytic cells were removed, there was 36.4 +/- 4.6% survival in six experiments, compared with 52.8% survival in the presence of purified granulocytes (mean of two experiments) and 96.9 +/- 1% survival in the presence of purified T cells. There was never any significant killing in control mixtures that contained leukocytes with normal rabbit serum nor in those that contained anticryptococcal antibody without effector leukocytes. Significant antibody-dependent fungicidal activity was seen with ratios of effector to target cells as low as 6.25:1. These observations indicate that multiple types of peripheral blood leukocytes, excluding T cells, are capable of antibody-dependent fungicidal activity.

PubMed Disclaimer

References

    1. Infect Immun. 1972 Aug;6(2):162-7 - PubMed
    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
    1. J Exp Med. 1974 May 1;139(5):1262-82 - PubMed
    1. J Exp Med. 1972 Aug 1;136(2):207-15 - PubMed
    1. Immunology. 1973 Sep;25(3):459-69 - PubMed

Publication types

Substances

LinkOut - more resources